Skip to content

Application of nursing under the guidance of multi-protective theory during heparin sodium injection treatment for patients with xanthelasma

Application of nursing under the guidance of multi-protective theory during heparin sodium injection treatment for patients with xanthelasma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600123982
Enrollment
Unknown
Registered
2026-05-06
Start date
2025-06-03
Completion date
Unknown
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Xanthelasma (XP) is another term for xanthelasma, primarily occurring on the upper eyelid and around the inner canthus of patients, leading to the appearance of orange-yellow or suede-colored patches of various shapes. In the early stages, it is more common to have unilateral lesions, while in later stages, bilateral symmetrical lesions are more prevalent[1]. The pathological changes in XP mainly

Interventions

Observation group:None
Control group:None

Sponsors

Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.XP was clearly diagnosed by the dermatologist; 2.Age> 18 years; 3.No medical treatment was received before the visit; 4.The case data are complete;

Exclusion criteria

Exclusion criteria: 1.Merge with other skin lesions; 2.There are serious multiple eyelid xanthomas; 3.cicatricial diathesis; 4.Combine severe underlying diseases; 5.There is a serious dependence on alcohol or drugs; 6.There are mental or cognitive diseases that cannot be well treated and studied;

Design outcomes

Primary

MeasureTime frame
Psychological state before and after treatment;Comparative quality of life;Treatment compliance;

Countries

China

Contacts

Public ContactXijuan Wang

Sun Yat-sen Memorial Hospital, Sun Yat-sen University

77xijuan@163.com+86 15817056797

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 16, 2026